The development of new cancer therapies based on the molecular identification of cancer regression antigens.
Year: 1995
Type: article
Source: PubMed
Author: S A Rosenberg
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2411032233